1.
Pang D, Dias MS, Ahab-Barmada M: Split cord malformation. I. A unified theory of embryogenesis for double spinal cord malformations. Neurosurgery 1992;31:451-480.
2.
Forrester MB, Merz RD: Descriptive epidemiology of lipomyelomeningocele, Hawaii, 1986-2001. Birth Defects Res A Clin Mol Teratol 2004;70:953-956.
3.
Naidich TP, Blaser SI, Delman BN, McLone DG, Dias MS, Zimmerman RA, Raybaud CA, Birchansky SB, Altman NR, Braffman BH: Congenital anomalies of the spine and spinal cord: embryology and malformations; in Atlas SW (ed): Magnetic Resonance Imaging of the Brain and Spine, ed 4. Philadelphia, Lippincott-Raven, 2008, pp 1364-1444.
4.
McLone DG, Naidich TP: Laser resection of fifty spinal lipomas. Neurosurgery 1986;18:611-615.
5.
Salunke P, Futane SS, Aggarwal A: Split cord malformation type II with twin dorsal lipomas. J Neurosurg Pediatr 2012;9:627-629.
6.
Kim MJ, Yoon SH, Cho KH, Won GS: Tethered spinal cord with double spinal lipomas. J Korean Med Sci 2006;21:1133-1135.
7.
Endo T, Yoshida Y, Shirane R, Yoshimoto T: Tethered spinal cord with double lipomas. Case illustration. J Neurosurg 2001;95:277.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.